Global Nucleic Acid and Oligonucleotide Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Nucleic acid drugs, also known as nucleic acid-based therapeutics, are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
The global Nucleic Acid and Oligonucleotide Therapeutics market size is projected to grow from US$ 12670 million in 2024 to US$ 15900 million in 2030; it is expected to grow at a CAGR of 3.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Nucleic Acid and Oligonucleotide Therapeutics Industry Forecast” looks at past sales and reviews total world Nucleic Acid and Oligonucleotide Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid and Oligonucleotide Therapeutics sales for 2023 through 2029. With Nucleic Acid and Oligonucleotide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid and Oligonucleotide Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid and Oligonucleotide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid and Oligonucleotide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid and Oligonucleotide Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid and Oligonucleotide Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid and Oligonucleotide Therapeutics.
United States market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nucleic Acid and Oligonucleotide Therapeutics players cover Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid and Oligonucleotide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic acid drugs, also known as nucleic acid-based therapeutics, are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
The global Nucleic Acid and Oligonucleotide Therapeutics market size is projected to grow from US$ 12670 million in 2024 to US$ 15900 million in 2030; it is expected to grow at a CAGR of 3.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Nucleic Acid and Oligonucleotide Therapeutics Industry Forecast” looks at past sales and reviews total world Nucleic Acid and Oligonucleotide Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid and Oligonucleotide Therapeutics sales for 2023 through 2029. With Nucleic Acid and Oligonucleotide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid and Oligonucleotide Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid and Oligonucleotide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid and Oligonucleotide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid and Oligonucleotide Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid and Oligonucleotide Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid and Oligonucleotide Therapeutics.
United States market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nucleic Acid and Oligonucleotide Therapeutics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nucleic Acid and Oligonucleotide Therapeutics players cover Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid and Oligonucleotide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- BioNTech
- Pfizer
- Moderna Therapeutics
- Jazz Pharmaceuticals
- CureVac
- Regulus Therapeutics
- ProQR
- Secarna
- MiNA Therapeutics
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2030
2.1.2 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Nucleic Acid and Oligonucleotide Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Nucleic Acid and Oligonucleotide Therapeutics Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.3 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type
2.3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid and Oligonucleotide Therapeutics Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 COVID-19
2.4.4 Other
2.5 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application
2.5.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Player
3.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024)
3.1.2 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024)
3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS BY REGION
4.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024)
4.2 Global Nucleic Acid and Oligonucleotide Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.4 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.5 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.6 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024)
7.2 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.1.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.2 Canada Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.3 Mexico Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.4 Brazil Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid and Oligonucleotide Therapeutics Market Forecast
10.3.2 Japan Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.3 Korea Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.4 Southeast Asia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.5 India Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.6 Australia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.2 France Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.3 UK Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.4 Italy Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.5 Russia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.2 South Africa Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.3 Israel Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.4 Turkey Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.6 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Type (2025-2030)
10.7 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.3.3 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.4.3 Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.5.3 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.6.3 Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.7.3 Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.8.3 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.9.3 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.10.3 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.11.3 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.12.3 CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.13.3 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.14.3 ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.15.3 Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.16.3 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.17.3 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.18.3 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.19.3 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.20.3 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2030
2.1.2 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Nucleic Acid and Oligonucleotide Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Nucleic Acid and Oligonucleotide Therapeutics Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.3 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type
2.3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid and Oligonucleotide Therapeutics Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 COVID-19
2.4.4 Other
2.5 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application
2.5.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Player
3.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024)
3.1.2 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024)
3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS BY REGION
4.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024)
4.2 Global Nucleic Acid and Oligonucleotide Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.4 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.5 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
4.6 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024)
7.2 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID AND OLIGONUCLEOTIDE THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.1.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.2 Canada Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.3 Mexico Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.2.4 Brazil Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid and Oligonucleotide Therapeutics Market Forecast
10.3.2 Japan Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.3 Korea Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.4 Southeast Asia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.5 India Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.3.6 Australia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.2 France Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.3 UK Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.4 Italy Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.4.5 Russia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.2 South Africa Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.3 Israel Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.5.4 Turkey Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
10.6 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Type (2025-2030)
10.7 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Nucleic Acid and Oligonucleotide Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.3.3 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.4.3 Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.5.3 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.6.3 Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.7.3 Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.8.3 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.9.3 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.10.3 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.11.3 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.12.3 CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.13.3 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.14.3 ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.15.3 Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.16.3 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.17.3 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.18.3 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.19.3 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
11.20.3 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Nucleic Acid and Oligonucleotide Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered
Table 15. Nucleic Acid and Oligonucleotide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Table 20. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nucleic Acid and Oligonucleotide Therapeutics
Table 40. Key Market Challenges & Risks of Nucleic Acid and Oligonucleotide Therapeutics
Table 41. Key Industry Trends of Nucleic Acid and Oligonucleotide Therapeutics
Table 42. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Sarepta Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 47. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 48. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Sarepta Therapeutics Main Business
Table 50. Sarepta Therapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 53. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 57. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 58. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 62. Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 63. Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 67. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 68. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 72. Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 73. Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 77. Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 78. Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 82. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 83. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 87. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 88. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Moderna Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 92. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 93. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Moderna Therapeutics Main Business
Table 95. Moderna Therapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 98. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 102. CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 103. CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. Regulus Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 107. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 108. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Regulus Therapeutics Main Business
Table 110. Regulus Therapeutics Latest Developments
Table 111. ProQR Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 112. ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 113. ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 117. Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 118. Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNA Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 122. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 123. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. MiNA Therapeutics Main Business
Table 125. MiNA Therapeutics Latest Developments
Table 126. Sylentis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 127. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 128. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 132. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 133. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. Silence Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 137. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 138. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Silence Therapeutics Main Business
Table 140. Silence Therapeutics Latest Developments
Table 141. Dicerna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 142. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 143. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
Table 1. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Nucleic Acid and Oligonucleotide Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered
Table 15. Nucleic Acid and Oligonucleotide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Table 20. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nucleic Acid and Oligonucleotide Therapeutics
Table 40. Key Market Challenges & Risks of Nucleic Acid and Oligonucleotide Therapeutics
Table 41. Key Industry Trends of Nucleic Acid and Oligonucleotide Therapeutics
Table 42. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Sarepta Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 47. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 48. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Sarepta Therapeutics Main Business
Table 50. Sarepta Therapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 53. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 57. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 58. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 62. Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 63. Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 67. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 68. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 72. Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 73. Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 77. Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 78. Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 82. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 83. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 87. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 88. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Moderna Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 92. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 93. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Moderna Therapeutics Main Business
Table 95. Moderna Therapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 98. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 102. CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 103. CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. Regulus Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 107. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 108. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Regulus Therapeutics Main Business
Table 110. Regulus Therapeutics Latest Developments
Table 111. ProQR Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 112. ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 113. ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 117. Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 118. Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNA Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 122. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 123. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. MiNA Therapeutics Main Business
Table 125. MiNA Therapeutics Latest Developments
Table 126. Sylentis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 127. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 128. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 132. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 133. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. Silence Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 137. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 138. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Silence Therapeutics Main Business
Table 140. Silence Therapeutics Latest Developments
Table 141. Dicerna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors
Table 142. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered
Table 143. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid and Oligonucleotide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Nucleic Acid and Oligonucleotide Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid and Oligonucleotide Therapeutics in Neuromuscular Diseases
Figure 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Neuromuscular Diseases (2019-2024) & ($ millions)
Figure 12. Nucleic Acid and Oligonucleotide Therapeutics in hATTR
Figure 13. Global Nucleic Acid and Oligonucleotide Therapeutics Market: hATTR (2019-2024) & ($ millions)
Figure 14. Nucleic Acid and Oligonucleotide Therapeutics in COVID-19
Figure 15. Global Nucleic Acid and Oligonucleotide Therapeutics Market: COVID-19 (2019-2024) & ($ millions)
Figure 16. Nucleic Acid and Oligonucleotide Therapeutics in Other
Figure 17. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Other (2019-2024) & ($ millions)
Figure 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application in 2023
Figure 19. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player in 2023
Figure 20. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Figure 21. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 22. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 23. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Value Market Share by Country in 2023
Figure 26. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region in 2023
Figure 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 32. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 33. China Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 37. India Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country in 2023
Figure 40. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 43. France Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 56. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 57. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 59. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 60. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 61. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 62. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 63. China Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 64. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 65. Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 67. India Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 68. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 69. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 70. France Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 71. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 72. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 73. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 74. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 75. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 76. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 77. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 79. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Nucleic Acid and Oligonucleotide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Nucleic Acid and Oligonucleotide Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid and Oligonucleotide Therapeutics in Neuromuscular Diseases
Figure 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Neuromuscular Diseases (2019-2024) & ($ millions)
Figure 12. Nucleic Acid and Oligonucleotide Therapeutics in hATTR
Figure 13. Global Nucleic Acid and Oligonucleotide Therapeutics Market: hATTR (2019-2024) & ($ millions)
Figure 14. Nucleic Acid and Oligonucleotide Therapeutics in COVID-19
Figure 15. Global Nucleic Acid and Oligonucleotide Therapeutics Market: COVID-19 (2019-2024) & ($ millions)
Figure 16. Nucleic Acid and Oligonucleotide Therapeutics in Other
Figure 17. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Other (2019-2024) & ($ millions)
Figure 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application in 2023
Figure 19. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player in 2023
Figure 20. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Figure 21. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 22. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 23. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions)
Figure 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Value Market Share by Country in 2023
Figure 26. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region in 2023
Figure 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 32. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 33. China Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 37. India Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country in 2023
Figure 40. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 43. France Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 56. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 57. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 59. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 60. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 61. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 62. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 63. China Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 64. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 65. Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 67. India Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 68. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 69. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 70. France Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 71. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 72. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 73. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 74. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 75. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 76. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 77. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions)
Figure 79. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Application (2025-2030)
